Source:http://linkedlifedata.com/resource/pubmed/id/18081539
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-12-17
|
pubmed:abstractText |
Japanese encephalitis (JE) is a significant cause of human morbidity and mortality throughout Asia. Vaccines for JE have been available for many years and their use has been effective in reducing the incidence of JE disease in several countries but, as disease incidence has decreased, concerns regarding adverse events following immunisation have increased.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1744-7682
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
95-106
|
pubmed:meshHeading |
pubmed-meshheading:18081539-Animals,
pubmed-meshheading:18081539-Antibodies, Viral,
pubmed-meshheading:18081539-Clinical Trials as Topic,
pubmed-meshheading:18081539-Encephalitis, Japanese,
pubmed-meshheading:18081539-Encephalitis Virus, Japanese,
pubmed-meshheading:18081539-Humans,
pubmed-meshheading:18081539-Japanese Encephalitis Vaccines
|
pubmed:year |
2008
|
pubmed:articleTitle |
Current use and development of vaccines for Japanese encephalitis.
|
pubmed:affiliation |
University of Texas Medical Branch, Department of Microbiology and Immunology, Galveston, TX 77555-0609, USA.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|